Author:
Sadeghi Amir H.,Koldeweij Charlotte,Trujillo-de Santiago Grissel,Tannazi Milad,Hosseinnia Nikkie,Loosbroek Oscar van,Manbachi Amir,Taverne Yannick J. H. J.,Bogers Ad J. J. C.,Alvarez Mario Moisés
Abstract
For-profit biotechnological and pharmaceutical companies have played an essential role in the research and development (R&D) of innovative medical products and drugs for many decades and embody a trillion-dollar industry. The past decades have been marked by an increase in growth of social non-profit biotechnology companies and organizations led by entrepreneurs committed to solve (global) health issues. In this review, we define the concept of social bioentrepreneurship and consider the potential impact of such ventures on global health. We analyse the current status of non-profit biotechnology and clarify the strategy, motivation, funding, and marketing techniques of these enterprises. We find that these non-profit ventures mainly focus on neglected and rare diseases by using different but also similar funding, marketing, and business strategy approaches to for-profit biotechnology enterprises. We also identify good leadership, multidisciplinary teams, and public awareness as key components to achieve long-term survival and higher success rates. Challenges faced by bioentrepreneurs include the lack of a clearly defined regulatory environment or governmental incentives to support their endeavors. Overall, with this qualitative data review and market analysis we draw a promising picture of social non-profit bioentrepreneurship and underscore its current and future impact on global health issues.
Subject
Public Health, Environmental and Occupational Health
Reference89 articles.
1. The Global Use of Medicines: Outlook Through 20172017
2. Drug approvals and failures: implications for alliances;Czerepak;Nat Rev Drug Disc.,2008
3. The Top 10 Causes of Death2015
4. Bill& Melinda Gates Foundation
What We Do2015
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献